Cargando…
Gonadotropin-Releasing Hormone Agonist Induced Pituitary Apoplexy
Background: Gonadotropin-releasing hormone agonists (GnRHa), used in the treatment of prostate cancer (PC) and for reproductive purposes in women, have been implicated as the cause of pituitary apoplexy (PA), a potentially life-threatening condition. The pathophysiology of PA after GnRHa has not bee...
Autores principales: | Yu, Xiaoling, Guarda, Francisco J, Shiraliyeva, Naila, Haines, Melanie S, Saylor, Philip J, Nachtigall, Lisa B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090722/ http://dx.doi.org/10.1210/jendso/bvab048.1281 |
Ejemplares similares
-
PMON91 Late Presentation of Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist for Prostate Cancer Treatment
por: Raj, Rishi, et al.
Publicado: (2022) -
MON-239 Pituitary Apoplexy Induced by Gonadotropin-Releasing Hormone Agonist Administration: A Rare Complication of Prostate Cancer Treatment
por: Barbosa, Mariana Marques, et al.
Publicado: (2020) -
Pituitary Apoplexy and Fulminant Liver Failure
por: Khan, Mehvish, et al.
Publicado: (2021) -
FRI311 GnRH Agonist Induced Pituitary Apoplexy In A Patient With Gonadotropinoma
por: Madahar, Inderpreet, et al.
Publicado: (2023) -
SUN-420 Pituitary Apoplexy Associated With Apixaban
por: Fanous, Nada, et al.
Publicado: (2019)